Glioma Stem Cells as Immunotherapeutic Targets: Advancements and Challenges

Keenan Piper1,2, Lisa DePledge1,3, Michael Karsy4

  • 1Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, United States.

Frontiers in Oncology
|March 15, 2021
PubMed

Insights

Glioblastoma treatment remains limited, but targeting glioma stem cells (GSCs) shows promise for overcoming recurrence and resistance. This review explores GSC-focused strategies for improved glioblastoma patient outcomes.

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Glioblastoma is an aggressive primary brain tumor with poor prognosis.
  • Current treatments offer limited survival benefits, often exceeding 1-2 years.
  • Glioma stem cells (GSCs) are implicated in glioblastoma recurrence and treatment resistance.

Purpose of the Study:

  • To review recent advances in glioblastoma treatment strategies targeting GSCs.
  • To discuss the potential integration of GSC-targeting therapies into clinical practice.
  • To highlight novel approaches for overcoming glioblastoma resistance.

Main Methods:

  • Literature review of recent research on glioblastoma and GSCs.
  • Analysis of therapeutic strategies targeting GSCs.
  • Discussion of potential clinical applications and trial integration.

Main Results:

  • GSCs are key drivers of glioblastoma recurrence and therapeutic resistance.
  • Multiple strategies are emerging to target GSCs, including immunotherapy and epigenetic modulation.
  • Targeting GSCs offers a promising avenue for improving glioblastoma treatment efficacy.

Conclusions:

  • Targeting glioma stem cells represents a critical frontier in glioblastoma research.
  • Integrating GSC-specific therapies into clinical trials may enhance patient survival.
  • Further research is needed to fully elucidate and exploit GSC vulnerabilities in glioblastoma.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
824
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.4K